S. Maïga

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines

T. Rème, M. Jourdan, B. Klein, 2011, Haematologica.

Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction

S. Maïga, M. Amiot, S. Colla, 2013, Leukemia.

S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth

G. Cohen, S. Maïga, M. Amiot, 2018, Oncotarget.

Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK

S. Maïga, M. Amiot, C. Pellat-deceunynck, 2014, Cell Death and Disease.

Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma

S. Maïga, M. Amiot, C. Pellat-deceunynck, 2015, Oncotarget.